Related Experiment Video
Updated: Aug 7, 2026
09:19
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
Parkinson's disease in a Scottish city
British Medical Journal (Clinical Research Ed.)
|February 22, 1986
Summary
Idiopathic Parkinson's disease affects 164.2 per 100,000 people. This neurodegenerative disorder causes significant disability, particularly in older individuals, impacting mobility and cognitive function.
Area of Science:
- Neurology
- Epidemiology
- Geriatrics
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder.
- Understanding its community prevalence and impact is crucial for public health.
- Previous studies provide a basis for current epidemiological assessments.
Purpose of the Study:
- To determine the total prevalence of idiopathic Parkinson's disease in Aberdeen.
- To analyze age- and sex-specific prevalence rates.
- To assess the degree of disability and cognitive impairment in affected individuals.
Main Methods:
- Community-based epidemiological study.
- Inclusion of all diagnosed cases of idiopathic Parkinson's disease in the defined geographical area.
- Assessment of patient disability using standardized measures and cognitive function via the minimental state questionnaire.
Main Results:
- Total prevalence of idiopathic Parkinson's disease was 164.2/10^5 population.
- Prevalence increased significantly in older age groups, reaching 2.7% in men and 2.0% in women over 84.
- Mean age at onset was 65.3 years; 34.7% of patients experienced considerable disability, and 10.2% were wheelchair-bound or bedridden.
Conclusions:
- Idiopathic Parkinson's disease is a prevalent and disabling condition within the community.
- Disability is associated with advanced age and lower cognitive scores.
- Findings highlight the ongoing public health burden of Parkinson's disease.
More Related Videos
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...